Company Description
BioNexus Gene Lab Corp., through its subsidiaries, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia.
The company operates through three segments: Trading of Industrial Chemicals; Provision for Genomic Screening Services; and Investment Holding.
It offers various chemical raw material products, including polyester resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; polyester resin 9509, a general-purpose material used in the production of marine boats and water slides; and polyester resin 2802, which is used as a component in the pultrusion process.
The company’s products are used in producing various finished goods, such as handrails, bench tops, and automotive and aero parts; paneling for hospital, laboratory, and industrial clean rooms; and covers for various instruments used in manufacturing.
It also develops and provides non-invasive liquid biopsy tests for the early detection of biomarkers.
BioNexus Gene Lab Corp. was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.
| Country | Malaysia |
| Founded | 2017 |
| Industry | Specialty Chemicals |
| Sector | Materials |
| Employees | 30 |
| CEO | Su-Leng Tan |
Contact Details
Address: Menara UOA Bangsar, Unit A-28-7, Level 28, Tower A Kuala Lumpur, 59000 Malaysia | |
| Phone | 60 1 307 241 6898 |
| Website | bionexusgenelab.com |
Stock Details
| Ticker Symbol | BGLC |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001737523 |
| CUSIP Number | 090628108 |
| ISIN Number | US0906282076 |
| Employer ID | 26-2124961 |
| SIC Code | 8071 |
Key Executives
| Name | Position |
|---|---|
| Su-Leng Tan | Chief Executive Officer, President, Secretary and Director |
| Set Fui Chong | Chief Financial Officer |
| Kwan Wah Chan | Marketing Manager |
| Too Kam Tham | Managing Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jul 30, 2025 | 8-K | Current Report |
| Jun 23, 2025 | 8-K | Current Report |
| May 15, 2025 | 10-Q | Quarterly Report |
| Apr 30, 2025 | 8-K | Current Report |
| Apr 29, 2025 | 10-K/A | [Amend] Annual report |
| Apr 15, 2025 | 10-K | Annual Report |
| Apr 10, 2025 | 8-K | Current Report |
| Apr 3, 2025 | 8-K | Current Report |
| Mar 31, 2025 | NT 10-K | Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 |
| Mar 25, 2025 | 8-K | Current Report |